Belcanto
Ein Auszug aus dem Programm:
Session 4:
Chronic Fatigue Syndrome
Chairs: Dr John Coffin & Dr Judy Mikovits
11.15AM Invited lecture on Chronic fatigue syndrome: F. Ruscetti
11.45AM Prevalence of XMRV in CFS patients and healthy controls: B. Huber
12.00AM XMRV in Chronic Fatigue Syndrome: A Pilot Study: M. Hanson
12.15AM Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors: S. Lo
12.30AM Detection of infectious XMRV in the peripheral blood of chronic fatigue syndrome patients in the United Kingdom: J. Mikovits
4.15PM No evidence for XMRV in CFS and MS patients in Germany despite the ability of the virus to infect human blood cells in vitro.: N. Bannert
4.30PM Search for XMRV in Swedish patients with myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and prostate cancer; methods and results.: J. Blomberg
Weiterhin wird eine Präsentation von Dr. deMeirleir aus Belgien erwartet, der das Virus und eine dazugehörige spezifische immunnologische Signatur in europäischen Patienten entdeckt haben soll.
Session 4:
Chronic Fatigue Syndrome
Chairs: Dr John Coffin & Dr Judy Mikovits
11.15AM Invited lecture on Chronic fatigue syndrome: F. Ruscetti
11.45AM Prevalence of XMRV in CFS patients and healthy controls: B. Huber
12.00AM XMRV in Chronic Fatigue Syndrome: A Pilot Study: M. Hanson
12.15AM Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors: S. Lo
12.30AM Detection of infectious XMRV in the peripheral blood of chronic fatigue syndrome patients in the United Kingdom: J. Mikovits
4.15PM No evidence for XMRV in CFS and MS patients in Germany despite the ability of the virus to infect human blood cells in vitro.: N. Bannert
4.30PM Search for XMRV in Swedish patients with myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and prostate cancer; methods and results.: J. Blomberg
Weiterhin wird eine Präsentation von Dr. deMeirleir aus Belgien erwartet, der das Virus und eine dazugehörige spezifische immunnologische Signatur in europäischen Patienten entdeckt haben soll.